Source: YourIVFSuccess

Comparing success rates with other clinics

I encourage you to compare our results with other clinics in Western and Greater Sydney on www.yourivfsuccess.com.au. As Minerva Fertility, my own laboratory, has only been treating patients since 2024, our results so far are only available for 5th category, ‘Pregnancies per individual treatment attempt’.

This category shows the chance of a clinical pregnancy from each treatment performed in one year where an embryo transfer was intended. This includes both egg retrievals performed with the intention of transferring a fresh embryo and cycles where frozen embryos were thawed with the intention of transfer.

I am thrilled that we have had some of the highest clinical pregnancy rates by age in this category in our first two years of treating patients. The graph shows our latest pregnancy rates from 2025 compared to the latest national average available, from 1 Jan to 31 December 2024 (source www.yourivfsuccess.com.au).

Since I opened Minerva Fertility in February 2024:

47% of patients have achieved a live birth with an embryo from their 1st IVF stimulation cycle. 

30% of patients who had been unsuccessful elsewhere, have achieved a live birth with IVF.

My approach to IVF is different to most other clinics. I’ll explain how and why.

I focus on providing patients with a more streamlined and supportive experience, offering either a quicker path to a successful pregnancy or alternatively, a faster, clearer resolution if treatment proves unsuccessful due to factors like poor-quality eggs or embryos. This approach empowers patients with clarity and allows for informed decisions about their fertility journey. It is often more cost effective.

IVF success rates are best shown as live birth rates, allowing apple versus apple comparisons between clinics.

Minerva Fertility, my own laboratory, started treating patients in February 2024. The graphs show live birth rates but the numbers do not yet allow detailed analysis by age group.

Frozen Embryo Transfers After PGT-A Testing

I prioritise genetic testing of embryos (PGT-A) in older patients who achieve high-grade embryos. This approach significantly improves the chances of a successful pregnancy per embryo transfer, reduces stress, and is especially cost-effective for older patients.

I am thrilled with the live birth rates we’ve achieved so far.

For context, here is how our results compare to national data from ANZARD. Data from 1 Jan to 31 December 2024:

  • PGT-A tested embryos created at Minerva Fertility: 63% (n=30)

  • ANZARD national average: 43.6%

This highlights the success of embryos created in-house at Minerva Fertility. We will continue to update these figures as our data grows.

Fresh Embryo Transfers

My preference is only to transfer fresh embryos in young patients and older patients with only low grade embryos. Low grade embryos cannot be biopsied or genetically tested and often have a low likelihood of surviving cryopreservation. As a result, many patients undergoing fresh embryo transfers at our clinic are typically those with a poorer prognosis.

Despite this, our live birth rate per transfer in these cases is 31.3% (n=32), which is encouraging given the challenges faced.

In contrast, most other clinics routinely transfer untested fresh embryos for patients of all ages and embryo grades, both high and low quality. This standard practice significantly skews comparisons, as these clinics include a broader mix of patients and embryos.

Therefore the graph is comparing apples and oranges.

For more information or to discuss cost of treatment, please complete the form or call us on +61 2 8883 3200

BOOK AN APPOINTMENT